Season 25 Episode 107
Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data and shares clinical investigator perspectives on the role of TROP2-directed antibody-drug conj…
Published on 4 weeks ago
Season 25 Episode 106
Prof Susana Banerjee from The Institute of Cancer Research in London and Dr Ursula Matulonis from Dana-Farber Cancer Institute in Boston discuss important efficacy and safety data from the past year …
Published on 4 weeks, 1 day ago
Season 25 Episode 105
Ms Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer.
NCPD information and select pub…
Published on 4 weeks, 2 days ago
Season 25 Episode 104
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant …
Published on 1 month ago
Season 25 Episode 103
Dr Rashmi Chugh from Rogel Comprehensive Cancer Center in Ann Arbor, Michigan, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize major clinical findin…
Published on 1 month ago
Season 25 Episode 102
Prof Laurence Albiges and Dr Tian Zhang summarize major findings presented at the 2025 ASCO Annual Meeting and review relevant ongoing clinical trials for patients with renal cell carcinoma.
CME info…
Published on 1 month ago
Season 25 Episode 101
Dr Catherine Coombs and Dr William Wierda summarize major treatment advances in chronic lymphocytic leukemia presented at the 2025 American Society of Clinical Oncology Annual Meeting and review ongo…
Published on 1 month, 1 week ago
Season 25 Episode 100
Ms Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer.
NCPD information and select publications here.
Published on 1 month, 1 week ago
Season 25 Episode 99
Dr Ajay K Nooka from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss recent updates on a…
Published on 1 month, 1 week ago
Season 25 Episode 98
Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mu…
Published on 1 month, 1 week ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate